Table of Contents Author Guidelines Submit a Manuscript
Emergency Medicine International
Volume 2017 (2017), Article ID 8024356, 8 pages
https://doi.org/10.1155/2017/8024356
Research Article

Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled Trials

1University of Rochester Medical Center, Rochester, NY, USA
2Seton Dell Medical School Stroke Institute, Dell Children’s Medical Center, University Medical Center at Brackenridge, Austin, TX, USA
3University of Texas Southwestern Medical Center, Dallas, TX, USA
4Massachusetts General Hospital, Boston, MA, USA
5CSL Behring, King of Prussia, PA, USA
6UCLA Fielding School of Public Health, Los Angeles, CA, USA

Correspondence should be addressed to Majed A. Refaai; ude.retsehcor.cmru@iaafer_dejam

Received 4 May 2017; Accepted 6 August 2017; Published 19 September 2017

Academic Editor: Marco L. A. Sivilotti

Copyright © 2017 Majed A. Refaai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. P. Choudari and K. R. Palmer, “Acute gastrointestinal haemorrhage in patients treated with anticoagulant drugs,” Gut, vol. 36, no. 4, pp. 483-484, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Sarode, K. Matevosyan, R. Bhagat, C. Rutherford, C. Madden, and J. E. Beshay, “Rapid warfarin reversal: A 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage: Clinical article,” Journal of Neurosurgery, vol. 116, no. 3, pp. 491–497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Schulman, R. J. Beyth, C. Kearon, and M. N. Levine, “Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition),” Chest, vol. 133, no. 6, pp. 257S–298S, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Shehab, L. S. Sperling, S. R. Kegler, and D. S. Budnitz, “National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin,” Archives of Internal Medicine, vol. 170, no. 21, pp. 1926–1933, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. S. Landefeld and R. J. Beyth, “Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention,” The American Journal of Medicine, vol. 95, no. 3, pp. 315–328, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Palareti, N. Leali, S. Coccheri et al., “Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT),” Lancet, vol. 348, no. 9025, pp. 423–428, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. B. A. Steinberg, D. N. Simon, L. Thomas et al., “Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]),” American Journal of Cardiology, vol. 119, no. 10, pp. 1590–1595, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Yang, S. Stanworth, S. Hopewell, C. Doree, and M. Murphy, “Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials (CME),” Transfusion, vol. 52, no. 8, pp. 1673–1686, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Ageno, A. S. Gallus, A. Wittkowsky, M. Crowther, E. M. Hylek, and G. Palareti, “Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines,” Chest, vol. 141, no. 2, pp. e44S–e88S, 2012. View at Publisher · View at Google Scholar
  10. R. Sarode, L. Holland, T. E. Warkentin, M. Refaai, M. A. Crowther, and M. A. Johnston, “Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose,” Transfusion, vol. 49, no. 6, pp. 1171–1177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Baxter, “BEBULIN (Factor IX Complex), Nanofiltered and Vapor Heated,” 2012, https://www.baxalta.com/assets/documents/bebulin_pi.pdf.
  12. CSL Behring, “Kcentra® Highlights of Prescribing Information,” 2013, http://labeling.cslbehring.com/PI/US/Kcentra/EN/Kcentra-Prescribing-Information.pdf.
  13. Grifols Biologicals Inc, “Factor IX Complex, Profilnine SD Prescribing Information,” 2010, http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-bio-gen/documents/document/ucm261964.pdf.
  14. Octapharma, “Octaplex Summary of Product Characteristics,” 2013, https://www.medicines.org.uk/emc/medicine/21897.
  15. CSL Behring, “Beriplex P/N Summary of Product Characteristics,” 2016, https://www.medicines.org.uk/emc/medicine/20797.
  16. J. N. Goldstein, M. A. Refaai, T. J. Milling Jr. et al., “Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial,” The Lancet, vol. 385, no. 9982, pp. 2077–2087, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Sarode, T. J. Milling, M. A. Refaai et al., “Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase iiib study,” Circulation, vol. 128, no. 11, pp. 1234–1243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Pabinger, A. Tiede, U. Kalina, S. Knaub, R. Germann, and H. Ostermann, “Impact of infusion speed on the safety and effectivenes of prothrombin complex concentrate A prospective clinical trial of emergency anticoagulation reversal,” Annals of Hematology, vol. 89, no. 3, pp. 309–316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti, “Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition),” Chest, vol. 133, no. 6, pp. 160S–198S, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. G. Lee, S. Turnipseed, P. S. Romano et al., “Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: A randomized controlled trial,” Gastrointestinal Endoscopy, vol. 50, no. 6, pp. 755–761, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Bjorkman, A. Zaman, M. B. Fennerty, D. Lieberman, J. A. DiSario, and G. Guest-Warnick, “Urgent vs. elective endoscopy for acute non-variceal upper-GI bleeding: an effectiveness study,” Gastrointestinal Endoscopy, vol. 60, no. 1, pp. 1–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. G. Lim, K. Y. Ho, Y. H. Chan et al., “Urgent endoscopy is associated with lower mortality in high-risk but not low-risk nonvariceal upper gastrointestinal bleeding,” Endoscopy, vol. 43, no. 4, pp. 300–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. J. Milling Jr., M. A. Refaai, and J. N. Goldstein, “Thromboembolic events after vitamin K antagonist reversal with 4-factor prothrombin complex concentrate: exploratory analyses of two randomized, plasma-controlled studies,” Annals of Emergency Medicine, vol. 67, no. 1, pp. 96–105.e5, 2016. View at Publisher · View at Google Scholar
  24. Z. A. Radwan, Y. Bai, N. Matijevic et al., “An emergency department thawed plasma protocol for severely injured patients,” JAMA Surgery, vol. 148, no. 2, pp. 170–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Magee and A. Zbrozek, “Fluid overload is associated with increases in length of stay and hospital costs: Pooled analysis of data from more than 600 US hospitals,” ClinicoEconomics and Outcomes Research, vol. 5, no. 1, pp. 289–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Magee, C. Peters, and A. Zbrozek, “Analysis of inpatient use of fresh frozen plasma and other therapies and associated outcomes in patients with major bleeds from vitamin K antagonism,” Clinical Therapeutics, vol. 35, no. 9, pp. 1432–1443, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. D. R. Parker, X. Luo, J. J. Jalbert, and A. R. Assaf, “Impact of upper and lower gastrointestinal blood loss on healthcare utilization and costs: a systematic review,” Journal of Medical Economics, vol. 14, no. 3, pp. 279–287, 2011. View at Publisher · View at Google Scholar · View at Scopus